"Treatment Outcome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
| Descriptor ID |
D016896
|
| MeSH Number(s) |
E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
|
| Concept/Terms |
Clinical Effectiveness- Clinical Effectiveness
- Clinical Effectivenesses
- Effectiveness, Clinical
- Effectivenesses, Clinical
- Patient-Relevant Outcome
- Outcome, Patient-Relevant
- Outcomes, Patient-Relevant
- Patient Relevant Outcome
- Patient-Relevant Outcomes
- Clinical Efficacy
- Efficacy, Clinical
|
Below are MeSH descriptors whose meaning is more general than "Treatment Outcome".
Below are MeSH descriptors whose meaning is more specific than "Treatment Outcome".
This graph shows the total number of publications written about "Treatment Outcome" by people in this website by year, and whether "Treatment Outcome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 32 | 32 |
| 1997 | 2 | 46 | 48 |
| 1998 | 0 | 62 | 62 |
| 1999 | 1 | 77 | 78 |
| 2000 | 1 | 62 | 63 |
| 2001 | 2 | 90 | 92 |
| 2002 | 1 | 101 | 102 |
| 2003 | 1 | 142 | 143 |
| 2004 | 1 | 154 | 155 |
| 2005 | 1 | 180 | 181 |
| 2006 | 3 | 183 | 186 |
| 2007 | 2 | 259 | 261 |
| 2008 | 1 | 255 | 256 |
| 2009 | 1 | 276 | 277 |
| 2010 | 3 | 340 | 343 |
| 2011 | 2 | 418 | 420 |
| 2012 | 1 | 363 | 364 |
| 2013 | 2 | 471 | 473 |
| 2014 | 2 | 443 | 445 |
| 2015 | 1 | 433 | 434 |
| 2016 | 5 | 474 | 479 |
| 2017 | 4 | 515 | 519 |
| 2018 | 1 | 525 | 526 |
| 2019 | 1 | 466 | 467 |
| 2020 | 3 | 500 | 503 |
| 2021 | 4 | 456 | 460 |
| 2022 | 0 | 379 | 379 |
| 2023 | 0 | 368 | 368 |
| 2024 | 0 | 462 | 462 |
| 2025 | 0 | 449 | 449 |
| 2026 | 0 | 188 | 188 |
To return to the timeline,
click here.
Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Endoscopic Ultrasound-Guided Gallbladder Drainage: An Expert Review by the Foundation for Interventional and Therapeutic Endoscopy of a Technique in Evolution. J Clin Gastroenterol. 2026 09 01; 60(8):685-694.
-
The Safety and Efficacy of Colorectal Endoscopic Submucosal Dissection in the Elderly: A Large Western Analysis of 710 Lesions. J Clin Gastroenterol. 2026 Sep 01; 60(8):715-721.
-
Donor-specific transplant outcomes from BMT CTN 1702: a multicenter prospective biologic assignment trial. Blood Adv. 2026 Aug 25; 10(16):5543-5552.
-
Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure: The RAFT Clinical Trial. JAMA. 2026 Aug 11; 336(6):473-483.
-
Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial. Lancet Neurol. 2026 Aug; 25(8):721-730.
-
Rocuronium dose and first-attempt intubation success in the critically ill: secondary analysis of two multicenter trials. Am J Respir Crit Care Med. 2026 Aug 01; 212(8):1740-1749.
-
Emotion Regulation Treatment for Alcohol Use Disorder: Results of a Stage II Randomized Clinical Efficacy Trial. Alcohol Clin Exp Res (Hoboken). 2026 Aug; 50(8):e70350.
-
Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial. Nat Commun. 2026 07 30; 17(1).
-
VEMORA: Vaginal Estrogen versus non-hormonal MOisturizer in women Receiving Aromatase inhibitors: a randomized, controlled trial. Breast Cancer Res Treat. 2026 Jul 30; 218(2).
-
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD). Int Clin Psychopharmacol. 2026 Sep 01; 41(5):295-303.